These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

420 related items for PubMed ID: 6403640

  • 1. Improvement of iron removal from the reticuloendothelial system by liposome encapsulation of N,N'-bis[2-hydroxybenzyl]-ethylenediamine-N,N'-diacetic acid (HBED). Comparison with desferrioxamine.
    Lau EH, Cerny EA, Wright BJ, Rahman YE.
    J Lab Clin Med; 1983 May; 101(5):806-16. PubMed ID: 6403640
    [Abstract] [Full Text] [Related]

  • 2. Enhanced iron removal from liver parenchymal cells in experimental iron overload: liposome encapsulation of HBED and phenobarbital administration.
    Rahman YE, Cerny EA, Lau EH, Carnes BA.
    Blood; 1983 Jul; 62(1):209-13. PubMed ID: 6407548
    [Abstract] [Full Text] [Related]

  • 3. Development and evaluation of the improved iron chelating agents EHPG, HBED and their dimethyl esters.
    Hershko C, Grady RW, Link G.
    Haematologia (Budap); 1984 Jul; 17(1):25-33. PubMed ID: 6427069
    [Abstract] [Full Text] [Related]

  • 4. Chemical evaluation of HBED/Fe(3+) and the novel HJB/Fe(3+) chelates as fertilizers to alleviate iron chlorosis.
    López-Rayo S, Hernández D, Lucena JJ.
    J Agric Food Chem; 2009 Sep 23; 57(18):8504-13. PubMed ID: 19689133
    [Abstract] [Full Text] [Related]

  • 5. Microscopic localization of sterically stabilized liposomes in colon carcinoma-bearing mice.
    Huang SK, Lee KD, Hong K, Friend DS, Papahadjopoulos D.
    Cancer Res; 1992 Oct 01; 52(19):5135-43. PubMed ID: 1394121
    [Abstract] [Full Text] [Related]

  • 6. Liposome-encapsulated desferrioxamine in experimental iron overload.
    Lau EH, Cerny EA, Rahman YE.
    Br J Haematol; 1981 Apr 01; 47(4):505-18. PubMed ID: 7213574
    [Abstract] [Full Text] [Related]

  • 7. Effect of liposome-encapsulated meso-2,3-dimercaptosuccinic acid on mice exposed to lead through drinking water.
    Misra M, Behari JR.
    Boll Chim Farm; 1997 Nov 01; 136(10):611-4. PubMed ID: 9528168
    [Abstract] [Full Text] [Related]

  • 8. UV and fluorescence spectral changes induced by neodymium binding of N,N'-ethylenebis[2-(o-hydroxyphenolic)glycine] and N,N'-di(2-hydroxybenzyl)ethylenediamine-N,N' diacetic acid.
    Wang Z, Yang B.
    Spectrochim Acta A Mol Biomol Spectrosc; 2006 Nov 01; 65(3-4):946-9. PubMed ID: 16684618
    [Abstract] [Full Text] [Related]

  • 9. Novel double prodrugs of the iron chelator N,N'-bis(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic acid (HBED): Synthesis, characterization, and investigation of activation by chemical hydrolysis and oxidation.
    Thiele NA, Abboud KA, Sloan KB.
    Eur J Med Chem; 2016 Aug 08; 118():193-207. PubMed ID: 27128183
    [Abstract] [Full Text] [Related]

  • 10. HBED: A potential alternative to deferoxamine for iron-chelating therapy.
    Bergeron RJ, Wiegand J, Brittenham GM.
    Blood; 1998 Feb 15; 91(4):1446-52. PubMed ID: 9454776
    [Abstract] [Full Text] [Related]

  • 11. Differentially increased IL-6 mRNA expression in liver and spleen following injection of liposome-encapsulated haemoglobin.
    Zhu XL, Pacheco ND, Dick EJ, Rollwagen FM.
    Cytokine; 1999 Sep 15; 11(9):696-703. PubMed ID: 10479406
    [Abstract] [Full Text] [Related]

  • 12. Chronic liposome administration in mice: effects on reticuloendothelial function and tissue distribution.
    Allen TM, Murray L, MacKeigan S, Shah M.
    J Pharmacol Exp Ther; 1984 Apr 15; 229(1):267-75. PubMed ID: 6707942
    [Abstract] [Full Text] [Related]

  • 13. Enhanced biliary iron excretion with amphiphilic diethylenetriaminepentaacetic acid.
    Adams PC, Lin E, Barber KR, Grant CW.
    Hepatology; 1991 Dec 15; 14(6):1230-4. PubMed ID: 1959873
    [Abstract] [Full Text] [Related]

  • 14. HBED: the continuing development of a potential alternative to deferoxamine for iron-chelating therapy.
    Bergeron RJ, Wiegand J, Brittenham GM.
    Blood; 1999 Jan 01; 93(1):370-5. PubMed ID: 9864183
    [Abstract] [Full Text] [Related]

  • 15. The potential role of fucosylated cationic liposome/NFkappaB decoy complexes in the treatment of cytokine-related liver disease.
    Higuchi Y, Kawakami S, Yamashita F, Hashida M.
    Biomaterials; 2007 Jan 01; 28(3):532-9. PubMed ID: 16982089
    [Abstract] [Full Text] [Related]

  • 16. Effects of liposome dose and the presence of lymphosarcoma cells on blood clearance and tissue distribution of large unilamellar liposomes in mice.
    Ellens H, Morselt HW, Dontje BH, Kalicharan D, Hulstaert CE, Scherphof GL.
    Cancer Res; 1983 Jun 01; 43(6):2927-34. PubMed ID: 6687832
    [Abstract] [Full Text] [Related]

  • 17. Evaluation of iron-chelating agents in an in vivo system: potential usefulness of EHPG, a powerful iron-chelating drug.
    Hershko C, Grady RW, Link G.
    Br J Haematol; 1982 Jun 01; 51(2):251-60. PubMed ID: 7082583
    [Abstract] [Full Text] [Related]

  • 18. Phenolic aminocarboxylic acids as gallium-binding radiopharmaceuticals.
    Hunt FC.
    Nuklearmedizin; 1984 Jun 01; 23(3):123-5. PubMed ID: 6435093
    [Abstract] [Full Text] [Related]

  • 19. Liver-targeted gene transfer into a human hepatoblastoma cell line and in vivo by sterylglucoside-containing cationic liposomes.
    Hwang SH, Hayashi K, Takayama K, Maitani Y.
    Gene Ther; 2001 Aug 01; 8(16):1276-80. PubMed ID: 11509962
    [Abstract] [Full Text] [Related]

  • 20. Targeting small unilamellar liposomes to hepatic parenchymal cells by dose effect.
    Chow DD, Essien HE, Padki MM, Hwang KJ.
    J Pharmacol Exp Ther; 1989 Feb 01; 248(2):506-13. PubMed ID: 2918467
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.